The DISC and DMT innovations have shown encouraging results. Overall, the treatments show improved workflow and a clear reduction in the skin and fat tissue temperatures. In an increasing portion of treatments, sonications have proceeded at a faster pace compared to before installation of DISC and DMT. The frequency at which patients stop sonications due to the sensation of skin heating has been greatly reduced.
Adding MR-HIFU to the treatment options not only offers an effective and less invasive procedure for uterine fibroids patients, it also helps with patient recruitment for other departments. For some of the women specifically seeking out an institute for MR-HIFU treatment, the conventional surgical options or uterine embolization are better suited. These women can be referred internally.
The technology behind MR-HIFU has the potential to treat a wide variety of solid tumors. Treatment of uterine fibroids is merely the most mature application. In an earlier edition of Hot Spot, we covered the use of MR-HIFU for bone metastases. Several other oncology applications are currently being developed, such as prostate cancer treatment with MR-HIFU.